New Vaccine Design and Delivery Technologies

被引:45
|
作者
Kanekiyo, Masaru [1 ]
Ellis, Daniel [2 ,3 ]
King, Neil P. [2 ,4 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA
[2] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA
[3] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
来源
基金
美国国家卫生研究院;
关键词
universal influenza vaccine; antigen design; structure-based vaccine; protein engineering; nanoparticle; antigen display; mRNA vaccine; broadly neutralizing antibody; INFLUENZA-VIRUS HEMAGGLUTININ; GLOBULAR HEAD; BINDING; PROTEIN; LIVE; IMMUNOGENICITY; STABILIZATION; ATTENUATION; ANTIBODIES; STRATEGY;
D O I
10.1093/infdis/jiy745
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Technological advances in immunology, protein design, and genetic delivery have unlocked new possibilities for vaccine concepts and delivery technologies that were previously inaccessible. These next-generation vaccine design efforts are particularly promising in their potential to provide solutions to challenging targets for which conventional approaches have proven ineffective-for example, a universal influenza vaccine. In this perspective, we discuss emerging approaches to vaccine design and engineering based on recent insights into immunology, structural biology, computational biology, and immunoengineering. We anticipate that these cutting-edge, interdisciplinary approaches will lead to breakthrough vaccine concepts for ever-evolving and (re) emerging influenza viruses, with important ramifications for global public health.
引用
收藏
页码:S88 / S96
页数:9
相关论文
共 50 条
  • [21] Plant-based technologies: Potential for vaccine development and delivery
    Musiychuk, Konstantin
    Ugulava, Natalia
    Men, Vadint
    Yusibov, Vidadi
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2005, 41 : 18A - 18A
  • [22] NEW ADVANCES IN VACCINE DELIVERY SYSTEMS
    ELDRIDGE, JH
    STAAS, JK
    CHEN, DX
    MARX, PA
    TICE, TR
    GILLEY, RM
    SEMINARS IN HEMATOLOGY, 1993, 30 (04) : 16 - 25
  • [23] New cancer vaccine delivery vehicle
    不详
    THERAPEUTIC DELIVERY, 2010, 1 (02) : 223 - 223
  • [24] ASPECTS OF THE DESIGN AND DELIVERY OF MICROPARTICLES FOR VACCINE APPLICATIONS
    JENKINS, PG
    COOMBES, AGA
    YEH, MK
    THOMAS, NW
    DAVIS, SS
    JOURNAL OF DRUG TARGETING, 1995, 3 (01) : 79 - 81
  • [25] New Vaccine Technologies to Combat Outbreak Situations
    Rauch, Susanne
    Jasny, Edith
    Schmidt, Kim E.
    Petsch, Benjamin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [26] Product development plan for new vaccine technologies
    Ellis, RW
    VACCINE, 2001, 19 (13-14) : 1559 - 1566
  • [27] Plasmid vector design and technologies for DNA vaccine development
    Iurescia, S.
    Fioretti, D.
    Pierimarchi, P.
    Signori, E.
    Zonfrillo, M.
    Fazio, V. M.
    Rinaldi, M.
    HUMAN GENE THERAPY, 2013, 24 (12) : A168 - A169
  • [28] Viral glycoproteomes: technologies for characterization and outlook for vaccine design
    Bagdonaite, Ieva
    Vakhrushev, Sergey Y.
    Joshi, Hiren J.
    Wandall, Hans H.
    FEBS LETTERS, 2018, 592 (23) : 3898 - 3920
  • [29] Rational antibacterial vaccine design through genomic technologies
    Grandi, G
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2003, 33 (5-6) : 615 - 620
  • [30] Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
    Hong, Xiaoyun
    Wei, Liangming
    Wu, Fei
    Wu, Zaozhan
    Chen, Lizhu
    Liu, Zhenguo
    Yuan, Weien
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 945 - 952